NIGHTSTAR THERAPEUTICS PLC Operating Cash Flow
NIGHTSTAR THERAPEUTICS PLC reported Operating Cash Flow of -$11.36 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2019-05-10
- NIGHTSTAR THERAPEUTICS PLC net cash provided by (used in) operating activities for the quarter ending 2019-03-31 was -$11.36M.
- NIGHTSTAR THERAPEUTICS PLC net cash provided by (used in) operating activities for the quarter ending 2018-12-31 was -$16.97M.
- NIGHTSTAR THERAPEUTICS PLC net cash provided by (used in) operating activities for the quarter ending 2018-09-30 was -$4.50M.
- NIGHTSTAR THERAPEUTICS PLC net cash provided by (used in) operating activities for the quarter ending 2018-06-30 was -$15.23M.
- NIGHTSTAR THERAPEUTICS PLC net cash provided by (used in) operating activities for fiscal 2018 was -$45.63M.
- NIGHTSTAR THERAPEUTICS PLC net cash provided by (used in) operating activities for fiscal 2017 was -$25.80M.
- NIGHTSTAR THERAPEUTICS PLC net cash provided by (used in) operating activities for fiscal 2016 was -$10.12M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2019-03-31 | -$11.36M 10-Q · filed 2019-05-10 | -$28.34M derived: sum of 2 quarters · filed 2019-05-10 | -$32.84M derived: sum of 3 quarters · filed 2019-05-10 | -$48.07M derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-12-31 | -$16.97M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | -$21.48M derived: sum of 2 quarters · filed 2019-03-18 | -$36.71M derived: sum of 3 quarters · filed 2019-03-18 | -$45.63M 10-K · filed 2019-03-18 |
| 2018-09-30 | -$4.50M derived: 6-K 9 month − 6-K 6 month · filed 2018-11-20 | -$19.74M derived: sum of 2 quarters · filed 2018-11-20 | -$28.66M 6-K · filed 2018-11-20 | -$39.05M derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-06-30 | -$15.23M derived: 6-K 6 month − 10-Q 3 month · filed 2018-08-15 | -$24.16M 6-K · filed 2018-08-15 | -$34.54M derived: sum of 3 quarters · filed 2019-05-10 | -$44.25M derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-03-31 | -$8.92M 10-Q · filed 2019-05-10 | -$19.31M derived: sum of 2 quarters · filed 2019-05-10 | -$29.02M derived: sum of 3 quarters · filed 2019-05-10 | |
| 2017-12-31 | -$10.39M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | -$20.09M derived: sum of 2 quarters · filed 2019-03-18 | -$25.80M 10-K · filed 2019-03-18 | |
| 2017-09-30 | -$9.71M derived: 6-K 9 month − 6-K 6 month · filed 2018-11-20 | -$15.41M 6-K · filed 2018-11-20 | ||
| 2017-06-30 | -$5.70M 6-K · filed 2018-08-15 | |||
| 2016-12-31 | -$10.12M 10-K · filed 2019-03-18 |